- Conditions
- Facet Joints; Degeneration, Neuralgia, Neuropathy
- Interventions
- Cryoablation under image guidance, MRI Seednet Cryotherapy System (Galil Medical)
- Procedure · Device
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2030
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 409–432
of 704
matching trials from the local directory fallback.
- Conditions
- Cancer of the Prostate, Neoplasms Prostate
- Interventions
- Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer
- Device
- Lead sponsor
- Urological Research Network, LLC
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2038
- U.S. locations
- 1
- States / cities
- Miami Lakes, Florida
- Conditions
- Cancer of the Prostate, Neoplasms Prostate
- Interventions
- FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY
- Procedure
- Lead sponsor
- Urological Research Network, LLC
- Other
- Eligibility
- 55 Years and older · Male only
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2033
- U.S. locations
- 1
- States / cities
- Miami Lakes, Florida
- Conditions
- Adverse Reaction to Vaccine, COVID19 Vaccine
- Interventions
- AZD1222, BBV152, BNT162b2, CVnCoV, CoronaVac, Gam-COVID-Vac, JNJ-78436735, NVX-CoV2373, Sinopharm, mRNA-1273
- Biological
- Lead sponsor
- Masaryk University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Rectal Adenocarcinoma
- Interventions
- MRI-guided radiotherapy by on-board DWI sequences
- Device
- Lead sponsor
- Institut Paoli-Calmettes
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- E-Cig Use
- Interventions
- Hyperpolarized Xenon -129 MRI
- Drug
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2025
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Hyperpolarized Xenon-129 MRI (Experimental), Radioactive Xenon-133 scintigraphy (Active Comparator)
- Drug
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Heart Failure, Systolic
- Interventions
- CMR/CTA Guidance for CRT
- Diagnostic Test
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 20 Years to 90 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Breast Cancer
- Interventions
- accelerated partial breast irradiation - 3D-conformal planning, accelerated partial breast irradiation - IMRT planning
- Radiation
- Lead sponsor
- Rocky Mountain Cancer Centers
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 660 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2028
- U.S. locations
- 5
- States / cities
- Aurora, Colorado • Boulder, Colorado • Lakewood, Colorado + 2 more
- Conditions
- Stress Disorders, Post-Traumatic
- Interventions
- Active MRI-Guided intermittent theta burst stimulation (iTBS), Sham MRI-Guided intermittent theta burst stimulation (iTBS)
- Device
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2031
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Brain Metastases From Solid Tumors, Brain Tumor, Brain Tumor Adult, Brain Tumor, Primary
- Interventions
- Blood sample, Brain Health Assessment, Brain magnetic resonance imaging (MRI), Quality of Life (QoL) Questionnaire
- Procedure · Radiation
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Healthy Adult Participants
- Interventions
- Functional Connectivity fMRI Neurofeedback, ROI-Activity fMRI Neurofeedback
- Behavioral
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Pancreatic Cancer
- Interventions
- Induction Chemotherapy - FOLFIRINOX, Induction Chemotherapy - Gemcitabine and Nab-Paclitaxel, MR-LINAC Guided Radiotherapy, Surgical Exploration and Resection
- Drug · Radiation · Procedure
- Lead sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Seasonal Influenza
- Interventions
- Fluarix Trivalent, mRNA-1010
- Biological
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Eligibility
- 9 Years to 17 Years
- Enrollment
- 96 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 6
- States / cities
- Modesto, California • Aurora, Colorado • Minneapolis, Minnesota + 3 more
- Conditions
- Consciousness, Level Altered
- Interventions
- Functional Magnetic Resonance Imaging (fMRI), Low-intensity focused ultrasound pulsation (LIFUP), Magnetic Resonance Spectroscopy, Multi-modal glymphatic function MRI
- Device
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2032
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Brain Neoplasm, Glioma, Recurrent High-Grade Gliomas
- Interventions
- Blood Specimen Collection, Magnetic Resonance Imaging (MRI), SRN-101, Surgical Resection
- Procedure · Drug
- Lead sponsor
- Nicholas Butowski
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Breast MRI
- Interventions
- Breast MRI, Standard of care contrast agent, provided in split dose
- Diagnostic Test · Drug
- Lead sponsor
- Manojkumar Saranathan
- Other
- Eligibility
- 30 Years to 89 Years · Female only
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
- Conditions
- SARS-CoV-2
- Interventions
- mRNA-1273, mRNA-1283
- Biological
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 5
- States / cities
- Overland Park, Kansas • Louisville, Kentucky • Charlotte, North Carolina + 2 more
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- 3'-Deoxy-3'-[18F]-fluorothymidine, Chemical-shift-encoded MRI
- Drug · Device
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Liver Diseases
- Interventions
- Ensure Plus Nutrition Shake, Novel MRI Software
- Other · Device
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 7 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2027 – 2029
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Epilepsy
- Interventions
- Sham Stimulation, Structural and Functional MRI, TES-TI
- Other · Device
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Metabolic Syndrome
- Interventions
- Indomethacin, MRI, Placebo
- Drug · Diagnostic Test
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Breast Cancer, Cancer of the Breast, Hodgkin Lymphoma, Lymphoma Cancer, Non-Hodgkin Lymphoma
- Interventions
- 18F-FDG, 68Ga-Galmydar, PET/MRI
- Drug · Device
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 21 Years to 99 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Interventions
- Biospecimen Collection, Electronic Health Record Review, SARS-CoV-2 mRNA Vaccine ARCT-021, Survey Administration, Tozinameran
- Procedure · Other · Biological
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Seattle, Washington